Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Abiomed, Inc.
  6. Summary
    ABMD   US0036541003

ABIOMED, INC.

(ABMD)
 SummaryQuotesChartsNewsRatingsCalendarCompanyFunds 
Quotes 5-day view   End-of-day quote. End-of-day quote Nasdaq
12/15/2022 12/16/2022 12/19/2022 12/20/2022 12/21/2022 Date
380.16 381 381.3 380.79 381.02 Last
834551 1538419 1365881 2401328 20612260 Volume
+0.01% +0.22% +0.08% -0.13% +0.06% Change
Company
Abiomed, Inc. specializes in the development, manufacturing and marketing of medical devices to assist or replace the pumping function of the failing heart. Net sales break down by activity as follows: - sale of products (95.4%): heart pumps (Impella brand); - sale of services (4.6%): including preventive maintenance services. Net sales are distributed geographically as follows: the United States (81.2%), Europe... 
Read more
More about the company
Ratings of Abiomed, Inc.
Trading Rating : 
Investor Rating :  -
ESG Refinitiv : 
B-
More Ratings
All news about ABIOMED, INC.
2022Abiomed Inc : Completion of Acquisition or Disposition of Assets, Notice of Delisting or F..
AQ
2022ABIOMED, Inc. Announces Management Changes
CI
2022ABIOMED, Inc. Announces Termination of Michael R. Minogue as Chief Executive Officer
CI
2022ABIOMED, Inc. Announces Termination of Todd A. Trapp as Chief Financial Officer
CI
2022Johnson & Johnson Closes Acquisition of Abiomed
MT
2022Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P 500 Health Care Equ..
CI
2022Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P Global BMI Index
CI
2022Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P TMI Index
CI
2022Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P 500 Equal Weighted
CI
2022Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P 500
CI
2022Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P 500 Growth
CI
2022Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P 500 Health Care Equ..
CI
2022Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P 500 Health Care
CI
2022Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P Composite 1500
CI
2022Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P 500 Health Care Equ..
CI
More news
News in other languages on ABIOMED, INC.
2022J&J : finalise l'acquisition d'Abiomed
2022ABIOMED, Inc. annonce des changements de direction
2022ABIOMED, Inc. annonce le licenciement de Michael R. Minogue en tant que chef de la dire..
2022Johnson & Johnson conclut l'acquisition d'Abiomed
2022Johnson & Johnson (NYSE:JNJ) a finalisé l'acquisition d'Abiomed,..
More news
Analyst Recommendations on ABIOMED, INC.
More recommendations
ETFs positioned on ABIOMED, INC.ETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
Robo Global Healthcare Technology and Innov...1.62%3.48%World
L&G Healthcare Breakthrough - Acc - USD1.6%4.02%-World
Invesco S&P 500� Equal Weight H...1.52%1.68%United_States
BMO Equal Weight U.S. Health Care Hedged to...1.41%1.11%United_States
BMO Equal Weight US Health Care Index ETF - CAD1.34%0.00%United_States
More ETFs positioned on ABIOMED, INC.
Analysis
J&J to buy Abiomed in $16.6 billion deal
Chart ABIOMED, INC.
Duration : Period :
Abiomed, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Managers and Directors
Thorsten Sieß Chief Technology Officer & Executive VP
Charles A. Simonton Chief Medical Officer & Executive Vice President
Laxmi N. Peri Senior Vice President-Engineering
Matt Plano Executive Vice President-Global Operations
David Fortunati Director
Sector and Competitors
1st jan.Capi. (M$)
ABIOMED, INC.6.08%17 188
THERMO FISHER SCIENTIFIC4.63%231 606
DANAHER CORPORATION-0.63%196 532
INTUITIVE SURGICAL, INC.-6.17%90 000
BOSTON SCIENTIFIC CORPORATION4.82%69 467
SIEMENS HEALTHINEERS AG12.82%65 645